Treatment of central line-associated bloodstream infections

Diagnosing and reporting of central line-associated bloodstream infections.

BACKGROUND The diagnosis of central line-associated bloodstream infections (CLABSIs) is often controversial, and existing guidelines differ in important ways. OBJECTIVE To determine both the range of practices involved in obtaining blood culture samples and how central line-associated infections are diagnosed and to obtain members' opinions regarding the process of designating bloodstream inf...

Impact of bundle for central line associated bloodstream infections prevention

Introduction / objectives Bundles have been developed to facilitate the application of infection control guidelines. Because in our institution the rates of central line associated bloodstream infections (CL-BSI) were above the international standards it was decided to implement a specific bundle through a multimodal approach. The aim of this study was to describe the strategy of bundle impleme...

Prevention of Central Line-Associated Bloodstream Infections: Brief Update Review

Seven years of zero central-line-associated bloodstream infections.

Many hospitals feel they have adequately addressed the issue of bloodstream infection prevention if they mandate a conventional central-line bundle. Yet central-line-associated bloodstream infections (CLABSIs) persist as a major problem in health care today. Sutter Roseville Medical Center (SRMC) in Roseville, California has achieved unprecedented success in eliminating CLABSIs by approaching t...

Strategies to Prevent Central Line-Associated Bloodstream Infections

Previously published guidelines are available that provide comprehensive recommendations for detecting and preventing healthcare-associated infections (HAIs). The intent of this document is to highlight practical recommendations in a concise format designed to assist acute care hospitals in implementing and prioritizing their central line-associated bloodstream infection (CLABSI) prevention eff...